FDA CDRH 510(k) Cardiac Monitor Guidance

“Cardiac Monitor Guidance (including Cardiotachometer and Rate Alarm)”

This doument was issued on November 5, 1998. This guidance is for preperation of 510(k) submissions for devices regulated under 21CFR 870.2300. In the scope section of this guidance it states that if the processing at the central station is for generating heart rate alarms then the device will be considered of regulatory class II. However, if the processing at the central station involves real time anrithria detection and alarams, then the device is in class III and is not covered by this guidance document. It also states that this guidance does not address issues specific to central monitoring stations, network devices, or devices that use telemetry or transtelphonic communications

Section II.A item five requires at a minimum indentification of all components and accessories that can be used with the monitor and gives examples of persoal computers, printers, and database management software.

Section II.D.2 references the current FDA software submission guidance and states that these cardiac monitors can be considered to have level of concern from minor to moderate depending on their exact intended use and function.

This guidance document also has a section that provides a suggested format and contents for test reports inculding test protocols, data results, and analysis. Although not specifically identifiying its use for software testing the information provided can be assumed to apply for the device overall including software functional testing and is fairly specific about the requirements for information to be included in these test reports.

SoftwareCPR Training Courses:

Being Agile & Yet Compliant (Public)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for registration!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

3 days virtual (Zoom) with group exercises, quizzes, examples, Q&A.

Lead Instructor: Mike Russell

Next public offering: Dec 3, 4, & 5, 2024 – 12:00 pm to 5:00 pm CET

Register Now


 

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Call or email now to schedule a private, in-house class. The fall schedule is filling up!

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.